Dose proportional inhibition of HIV-1 replication by mycophenolic acid and synergistic inhibition in combination with abacavir, didanosine, and tenofovir (Q44036706)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Dose proportional inhibition of HIV-1 replication by mycophenolic acid and synergistic inhibition in combination with abacavir, didanosine, and tenofovir	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

29 November 2017

Dose proportional inhibition of HIV-1 replication by mycophenolic acid and synergistic inhibition in combination with abacavir, didanosine, and tenofovir (English)

1 reference

Europe PubMed Central

29 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

David M. Margolis

4

1 reference

Europe PubMed Central

29 November 2017

author name string

Mohammad M Hossain

1

1 reference

Europe PubMed Central

29 November 2017

Jason J Coull

2

1 reference

Europe PubMed Central

29 November 2017

George L Drusano

3

1 reference

Europe PubMed Central

29 November 2017

publication date

1 July 2002

1 reference

Europe PubMed Central

29 November 2017

Antiviral Research

1 reference

Europe PubMed Central

29 November 2017

55

1 reference

Europe PubMed Central

29 November 2017

1

1 reference

Europe PubMed Central

29 November 2017

41-52

1 reference

Europe PubMed Central

29 November 2017

Mechanisms of Action of Mycophenolic Acid

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900006-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Mycophenolate mofetil and its mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900006-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2-phosphonomethoxypropyl)-2,6-diaminopurine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900006-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900006-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety, pharmacokinetics, and antiretroviral activity of intravenous 9-[2-(R)-(Phosphonomethoxy)propyl]adenine, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900006-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900006-2

7 January 2021

based on heuristic

inferred from DOI database lookup

K65R mutation of human immunodeficiency virus type 1 reverse transcriptase encodes cross-resistance to 9-(2-phosphonylmethoxyethyl)adenine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900006-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900006-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900006-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Polymerase substrate depletion: a novel strategy for inhibiting the replication of the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900006-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900006-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Abacavir and mycophenolic acid, an inhibitor of inosine monophosphate dehydrogenase, have profound and synergistic anti-HIV activity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900006-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Unblocking of chain-terminated primer by HIV-1 reverse transcriptase through a nucleotide-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900006-2

7 January 2021

based on heuristic

inferred from DOI database lookup

IMP dehydrogenase inhibitors as immunomodulators

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900006-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term inhibition of human T-lymphotropic virus type III/lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 2',3'-dideoxynucleosides in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900006-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Structure-activity relationships for inhibition of inosine monophosphate dehydrogenase by nuclear variants of mycophenolic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900006-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Mycophenolate mofetil strongly potentiates the anti-herpesvirus activity of acyclovir.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900006-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The antiherpesvirus activity of H2G [(R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine] is markedly enhanced by the novel immunosuppressive agent mycophenolate mofetil.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900006-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Phosphonylmethoxyethyl purine derivatives, a new class of anti-human immunodeficiency virus agents

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900006-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I/II study of 2'-deoxy-3'-thiacytidine (lamivudine) in patients with advanced human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900006-2

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900006-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-human immunodeficiency virus activity and cellular metabolism of a potential prodrug of the acyclic nucleoside phosphonate 9-R-(2-phosphonomethoxypropyl)adenine (PMPA), Bis(isopropyloxymethylcarbonyl)PMPA

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900006-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900006-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of PMPA and PMEA on the kinetics of viral load in simian immunodeficiency virus-infected macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900006-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900006-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Susceptibility of human immunodeficiency virus type 1 replication in vitro to acyclic adenosine analogs and synergy of the analogs with 3'-azido-3'-deoxythymidine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900006-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of (R)-9-(2-phosphonylmethoxypropyl)adenine monotherapy on chronic SIV infection in macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900006-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylactic and therapeutic benefits of short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) administration to newborn macaques following oral inoculation with simian immunodeficiency virus with reduced susceptibility to PMPA.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900006-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of mycophenolate mofetil therapy on inosine monophosphate dehydrogenase induction in red blood cells of heart transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900006-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Transmission of antiretroviral-drug-resistant HIV-1 variants

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900006-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0166-3542(02)00006-2

1 reference

Europe PubMed Central

29 November 2017

1 reference

Europe PubMed Central

29 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44036706&oldid=2105834520"